Cargando…

Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study

BACKGROUND: Individuals with a family history of Parkinson’s disease (PD) appear to have a higher risk of developing PD and other neuropsychiatric diseases. However, estimates of the relative risks (RRs) of PD and the roles of genetic and environmental factors in PD susceptibility are unclear. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fu-Chao, Lin, Huan-Tang, Kuo, Chang-Fu, Hsieh, Mei-Yun, See, Lai-Chu, Yu, Huang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985793/
https://www.ncbi.nlm.nih.gov/pubmed/29881310
http://dx.doi.org/10.2147/CLEP.S164330
_version_ 1783328821947138048
author Liu, Fu-Chao
Lin, Huan-Tang
Kuo, Chang-Fu
Hsieh, Mei-Yun
See, Lai-Chu
Yu, Huang-Ping
author_facet Liu, Fu-Chao
Lin, Huan-Tang
Kuo, Chang-Fu
Hsieh, Mei-Yun
See, Lai-Chu
Yu, Huang-Ping
author_sort Liu, Fu-Chao
collection PubMed
description BACKGROUND: Individuals with a family history of Parkinson’s disease (PD) appear to have a higher risk of developing PD and other neuropsychiatric diseases. However, estimates of the relative risks (RRs) of PD and the roles of genetic and environmental factors in PD susceptibility are unclear. The aim of this study was to examine familial aggregation and genetic contributions to PD and the RRs of other neuropsychiatric diseases in relatives of PD patients. METHODS: In this population-based family cohort study, the records of all individuals actively registered in the Taiwan National Health Insurance Research Database in 2015 were queried (N=24,349,599). In total, 149,187 individuals with a PD-affected parent, 3,698 with an affected offspring, 3,495 with an affected sibling, and 15 with an affected twin were identified. Diagnoses of PD were ascertained between January 1, 1999, and December 31, 2015. The prevalence and RRs of PD and other neuropsychiatric diseases in individuals with first-degree relatives with PD, as well as the contributions of heritability and environmental factors to PD susceptibility were investigated. RESULTS: The prevalence of PD was 0.46% in the general population and 0.52% in individuals with first-degree relatives with PD. The RR (95% CI) for PD was 2.20 (1.41–3.45) for siblings, 1.59 (1.47–1.73) for parents, 1.86 (1.63–2.11) for offspring, 63.12 (16.45–242.16) for twins, and 1.46 (1.41–1.52) for spouses. The RR (95% CI) in individuals with first-degree relatives with PD was 1.66 (1.57–1.76) for essential tremor, 1.68 (1.61–1.75) for schizophrenia, and 1.20 (1.12–1.28) for Alzheimer’s disease. The estimated contribution to the phenotypic variance of PD was 11.0% for heritability, 9.1% for shared environmental factors, and 79.9% for non-shared environmental factors. CONCLUSION: First-degree relatives of PD patients are more likely to develop PD and other neuropsychiatric diseases. Environmental factors account for a high proportion of the phenotypic variance of PD.
format Online
Article
Text
id pubmed-5985793
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59857932018-06-07 Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study Liu, Fu-Chao Lin, Huan-Tang Kuo, Chang-Fu Hsieh, Mei-Yun See, Lai-Chu Yu, Huang-Ping Clin Epidemiol Original Research BACKGROUND: Individuals with a family history of Parkinson’s disease (PD) appear to have a higher risk of developing PD and other neuropsychiatric diseases. However, estimates of the relative risks (RRs) of PD and the roles of genetic and environmental factors in PD susceptibility are unclear. The aim of this study was to examine familial aggregation and genetic contributions to PD and the RRs of other neuropsychiatric diseases in relatives of PD patients. METHODS: In this population-based family cohort study, the records of all individuals actively registered in the Taiwan National Health Insurance Research Database in 2015 were queried (N=24,349,599). In total, 149,187 individuals with a PD-affected parent, 3,698 with an affected offspring, 3,495 with an affected sibling, and 15 with an affected twin were identified. Diagnoses of PD were ascertained between January 1, 1999, and December 31, 2015. The prevalence and RRs of PD and other neuropsychiatric diseases in individuals with first-degree relatives with PD, as well as the contributions of heritability and environmental factors to PD susceptibility were investigated. RESULTS: The prevalence of PD was 0.46% in the general population and 0.52% in individuals with first-degree relatives with PD. The RR (95% CI) for PD was 2.20 (1.41–3.45) for siblings, 1.59 (1.47–1.73) for parents, 1.86 (1.63–2.11) for offspring, 63.12 (16.45–242.16) for twins, and 1.46 (1.41–1.52) for spouses. The RR (95% CI) in individuals with first-degree relatives with PD was 1.66 (1.57–1.76) for essential tremor, 1.68 (1.61–1.75) for schizophrenia, and 1.20 (1.12–1.28) for Alzheimer’s disease. The estimated contribution to the phenotypic variance of PD was 11.0% for heritability, 9.1% for shared environmental factors, and 79.9% for non-shared environmental factors. CONCLUSION: First-degree relatives of PD patients are more likely to develop PD and other neuropsychiatric diseases. Environmental factors account for a high proportion of the phenotypic variance of PD. Dove Medical Press 2018-05-30 /pmc/articles/PMC5985793/ /pubmed/29881310 http://dx.doi.org/10.2147/CLEP.S164330 Text en © 2018 Liu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Liu, Fu-Chao
Lin, Huan-Tang
Kuo, Chang-Fu
Hsieh, Mei-Yun
See, Lai-Chu
Yu, Huang-Ping
Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
title Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
title_full Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
title_fullStr Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
title_full_unstemmed Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
title_short Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
title_sort familial aggregation of parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985793/
https://www.ncbi.nlm.nih.gov/pubmed/29881310
http://dx.doi.org/10.2147/CLEP.S164330
work_keys_str_mv AT liufuchao familialaggregationofparkinsonsdiseaseandcoaggregationwithneuropsychiatricdiseasesapopulationbasedcohortstudy
AT linhuantang familialaggregationofparkinsonsdiseaseandcoaggregationwithneuropsychiatricdiseasesapopulationbasedcohortstudy
AT kuochangfu familialaggregationofparkinsonsdiseaseandcoaggregationwithneuropsychiatricdiseasesapopulationbasedcohortstudy
AT hsiehmeiyun familialaggregationofparkinsonsdiseaseandcoaggregationwithneuropsychiatricdiseasesapopulationbasedcohortstudy
AT seelaichu familialaggregationofparkinsonsdiseaseandcoaggregationwithneuropsychiatricdiseasesapopulationbasedcohortstudy
AT yuhuangping familialaggregationofparkinsonsdiseaseandcoaggregationwithneuropsychiatricdiseasesapopulationbasedcohortstudy